Figure 2From: A Cost-Consequences analysis of the effect of Pregabalin in the treatment of peripheral Neuropathic Pain in routine medical practice in Primary Care settings Weekly mean change in pain intensity according to the SF-MPQ VAS. VAS: Visual analogue scale; PGB: pregabalin; W1-W12: weeks 1 to 12; SF-MPQ: McGill Pain Questionnaire Short-Form. *p < 0.05, †p < 0.01, ‡p < 0.001 vs. Non-PGB group.Back to article page